ASCO Daily News

A podcast by American Society of Clinical Oncology (ASCO) - Thursdays

Thursdays

Categories:

101 Episodes

  1. Spotlight on Immunotherapy at ASCO23

    Published: 6/26/2023
  2. Highlights in Hematologic Malignancies at ASCO23 

    Published: 6/23/2023
  3. ADAURA, KEYNOTE-671, and Other Key Advances in Lung Cancer at ASCO23

    Published: 6/22/2023
  4. SONIA, NATALEE, and Other Advances in Breast Cancer at ASCO23

    Published: 6/21/2023
  5. Addressing the Impact of Prior Authorization on Access to Cancer Treatment

    Published: 6/8/2023
  6. ASCO23: RELATIVITY-047, CheckMate-038, and Other Advances in Immunotherapy

    Published: 5/25/2023
  7. ASCO23: COMMANDS, CAPTIVATE, and Key Studies in Hematologic Malignancies

    Published: 5/25/2023
  8. ASCO23: Novel Approaches in RCC, mUC, and Prostate Cancer

    Published: 5/25/2023
  9. ASCO23: CodeBreak-101, NAPOLI-3, and Other Advances in GI Cancers

    Published: 5/25/2023
  10. ASCO23: Novel Therapies in Lung Cancer 

    Published: 5/25/2023
  11. ASCO23: PALMIRA, LEONARDA-1, and Other Advances in Breast Cancer

    Published: 5/25/2023
  12. ASCO23: Key Abstracts from Precision Oncology to Cancer Disparities

    Published: 5/25/2023
  13. S2302 Pragmatica-Lung and the Promise of Streamlined Clinical Trials

    Published: 4/13/2023
  14. Advances in Neoadjuvant IO in MSI-H/dMMR Colorectal Cancer

    Published: 3/16/2023
  15. Key Abstracts in Prostate, Bladder, and Kidney Cancers at GU23

    Published: 3/2/2023
  16. ARASENS, TRITON3, and Other Key Advances at GU23

    Published: 2/13/2023
  17. SWOG 1815, PARADIGM, and Other Advances at GI23

    Published: 2/2/2023
  18. Fertility Concerns, Family Planning, and Career Decisions Among Female Oncologists

    Published: 1/5/2023
  19. What Challenges Will Oncologists Face in 2023?

    Published: 12/8/2022
  20. Developing the Next Generation of Prostate Cancer Researchers

    Published: 11/15/2022

2 / 6

The ASCO Daily News Podcast features oncologists discussing the latest research and therapies in their areas of expertise.